CURE Insider Trading Activity and SEC Form 4 Filings
CURE insider trading summary
No open-market insider purchases or sales of Curative Health Services Inc (CURE) have been reported on SEC Form 4 in the past 12 months.
Latest CURE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 13, 2006 | Timothy I Maudlin | Director | Sell | $3K (54,374 @ $0.05) |
| Apr 13, 2006 | Timothy I Maudlin | Director | Sell | $336 (5,595 @ $0.06) |
| Apr 13, 2006 | Timothy I Maudlin | Director | Sell | $621 (10,685 @ $0.06) |
| Dec 21, 2005 | Thomas Axmacher | EVP and CFO | Sell | $6K (20,000 @ $0.28) |
| Dec 19, 2005 | Thomas Axmacher | EVP and CFO | Sell | $509 (2,120 @ $0.24) |
| Dec 8, 2005 | Daniel E Berce | Director | Sell | $230 (1,000 @ $0.23) |
| Dec 8, 2005 | Daniel E Berce | Director | Sell | $3K (15,000 @ $0.20) |
| Dec 7, 2005 | Roy McKinley | SVP - Wound Care Management | Sell | $17K (84,948 @ $0.20) |
| Dec 6, 2005 | Paul S Auerbach | Director | Sell | $2K (15,000 @ $0.15) |
| Dec 6, 2005 | Paul F McConnell | Chief Executive Officer | Sell | $17K (84,496 @ $0.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.